http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-047969-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a7f82940e47ba7a1188f8e2ffca55e0f
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
filingDate 2005-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2006-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-047969-A1
titleOfInvention PIRAZOLOTRIAZINAS AS QUINASA INHIBITORS
abstract This refers to pyrazolotriazines as kinase inhibitors, methods of preparing said compounds; pharmaceutical compositions containing them and uses. Claim 1: A compound represented by structural formula (1) or a pharmaceutically acceptable salt, solvate or ester of said compound, wherein: R1 is selected from the group consisting of H, alkyl, aryl, heteroaryl, heteroarylalkyl, arylalkyl, NR6R7 , cycloalkyl and cycloalkylalkyl, wherein each of said alkyl, aryl, heteroaryl, heteroarylalkyl, cycloalkyl, cycloalkylalkyl and arylalkyl may be unsubstituted or optionally substituted independently with one or more portions, the same or different, wherein each is selected independently of the group consisting of halo, alkyl, aryl, heteroaryl, heterocyclyl, trifluoromethyl, OR6, NR6R7, SR6, SO2R6, .CN, SO2N (R6R7) and NO2; R2 is alkyl, cycloalkyl, alkenyl, alkynyl, trifluoromethyl, -OR7, - SR7, hydroxyalkyl, haloalkyl, aryl, heteroaryl, halo, CN, formyl, nitro, alkylcarbonyl, aralkylcarbonyl, heteroaralkylcarbonyl, or -alkylene-N (R8R9), ( where R8 and R9 independently represent H or alkyl, or R8 and R9 taken together with N in -N (R8R9) form a 5- to 7-membered heterocycle); R3 is -NR4R5, or as shown in the group of formulas (2), H, alkyl, alkylthio, aralkylthio, alkylsulfinyl, or aralkylsulfinyl; R4 is alkyl, cycloalkyl or heterocyclyl, wherein each of said alkyl, cycloalkyl and heterocyclyl can be unsubstituted or optionally substituted independently with 1 to 4 substituents, the same or different, wherein each substituent is independently selected from the group consisting of halo, alkyl, hydroxymethyl, hydroxyethyl, hydroxypropyl, trifluoromethyl, OR6, NR6R7, SR6, SO2R6, CN, SO2N (R6R7) and NO2; R5 is H, alkyl, aryl, heteroaryl, arylalkyl, cycloalkyl, heterocyclyl, acyl, or heteroarylalkyl; R6 is H, alkyl or aryl; R7 is H or alkyl; R10 is halo, alkyl, hydroxyalkyl, trifluoromethyl, OR6, NR6R7, SR6, SO2R6, CN, SO2N (R6R7) or NO2; and n is 0 to 4, and when n is 2 to 4, the portions n can be the same or different, where each is independently selected; with the following conditions: (1) that when R2 is C1-4 alkyl and R5 is H, then R4 is not a C1-4 alkyl; (2) that when R2 is halo, CN, formyl, nitro, alkylcarbonyl, aralkylcarbonyl, heteroaralkylcarbonyl, or -alkylene-N (R8R9), then: (a) R3 is not H, alkylthio, aralkylthio, alkylsulfinyl, aralkylsulfinyl, or - NR4R5; and (b) n is not 0; and (3) that when R2 is alkyl, cycloalkyl, alkenyl or alkynyl, then R3 is not NH (methyl), N, N (dimethyl), NH (acetyl) or N (methyl) (acetyl).
priorityDate 2004-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414037522
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392901
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457311044
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66624196

Total number of triples: 47.